Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. - Wikidata - awgldk - TriplyDB

Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.

Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.

http://www.wikidata.org/entity/Q37511097

about

Long-chain acyl-CoA synthetase 4 modulates prostaglandin E₂ release from human arterial smooth muscle cells Platelet signaling: a complex interplay between inhibitory and activatory networks Cigarette Smoke Amplifies Inflammatory Response and Atherosclerosis Progression Through Activation of the H1R-TLR2/4-COX2 Axis The contribution of prostaglandins versus prostacyclin in ventricular remodeling during heart failure Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation Elucidation of monocyte/macrophage dynamics and function by intravital imaging.Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2 Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysis Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets.Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production.Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis Anti-tumor effect of Liqi, a traditional Chinese medicine prescription, in tumor bearing mice.Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice.Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells.Enhanced tyrosine nitration of prostacyclin synthase is associated with increased inflammation in atherosclerotic carotid arteries from type 2 diabetic patients.Chronic ingestion of H1-antihistamines increase progression of atherosclerosis in apolipoprotein E-/- mice.Thromboxane and the thromboxane receptor in cardiovascular disease.Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2.Targeted deletions of cyclooxygenase-2 and atherogenesis in mice.Celecoxib does not attenuate the antiplatelet effects of aspirin and clopidogrel in healthy volunteers.Prostaglandins and inflammation.PG F(2α) Receptor: A Promising Therapeutic Target for Cardiovascular Disease.The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis.Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-oxLDL uptake.Hypercholesterolemia and microvascular dysfunction: interventional strategies.Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation.TP receptors and oxidative stress hand in hand from endothelial dysfunction to atherosclerosis.Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation.Internalization and recycling of the human prostacyclin receptor is modulated through its isoprenylation-dependent interaction with the delta subunit of cGMP phosphodiesterase 6.Adventures in vascular biology: a tale of two mediators.Clinical pharmacology of etoricoxib.Prostacyclin: an inflammatory paradox.Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB.Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation.Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.

P2860

Q24337408-4196CDD5-921B-4024-9C96-56F0CB7C06B4 Q26765384-C29121BF-2C7A-4497-A269-445304C67CDE Q26776119-CBE837D9-F251-455F-9781-3F76F7ACE5E0 Q26830372-9CCB59D9-AEA7-41AE-9001-6D013FC98C7B Q26864770-B53FCBEC-24A2-4820-AFC0-551B1C7DEDDC Q27313900-9554977D-1075-4B48-9605-0BD489D3F48F Q28210322-BD77E438-2C82-42D2-953F-580B397FC540 Q28274624-646E388E-86B1-4910-9554-F17E32AB614C Q28510556-D7D11067-21D5-496C-AB53-8CE99FAAD7C1 Q28534432-1C97E453-4427-4891-9761-2ACC394B6D3B Q30408017-2ABAF73D-D15A-49FD-B3D2-3705722064DF Q30423459-8345B51B-B54D-4605-A336-DC22378B7554 Q30494712-DCCDB406-B6AE-47C8-BC7C-65EB56522B15 Q33477092-E48BBA7E-12F2-46CD-9FF0-7AA9F956DC29 Q33607097-4C4EE0F1-FE6E-48F4-992B-81F1DD932AE5 Q33728222-2C391A17-0764-463F-AAED-EEFFFE3F03CC Q33816483-8DF4F7F1-F87F-4CD6-AB29-A9A1466C0D79 Q33895956-D46546BD-C93F-49EA-B3E5-66E4EBC15810 Q33899567-1FD1696A-F4BB-45E9-87F4-CE8E11A340A8 Q33937192-C558E3D0-8BF8-43A6-AB49-FCA22023EC47 Q34019117-FB7F45C7-9D36-4C7B-ADB6-F7CEF683C330 Q34021188-B8742DD7-7887-40EE-9800-D7701B4DACFF Q34179727-9BD3D7F5-FFF0-4E3B-AFD8-11554A2299A8 Q34186949-0B721CC4-62D9-4048-AB85-5539FEDBE81E Q34228685-A223F254-1A13-4A5B-A70F-95E6B4BB477E Q34245387-3E4A1843-3584-4A4A-A514-11C7C046DF12 Q34361591-A45D7000-8D8B-43AD-BF11-7BAA99C0FA69 Q34375542-DF02B47D-962E-43D8-9152-7CA21C3D333C Q34389439-A9C2F133-E01C-4533-A78A-5CC1AC3A7989 Q34415503-EB65ACAF-C68F-4A5B-B20E-C0E27B75211C Q34435166-C39371C5-A941-4716-8F94-561180CE805F Q34500980-3007D389-A265-42EA-AD49-7CEC84C3B219 Q34515584-183E2BA2-E30C-4458-885B-8CC1019B97CC Q34570225-11378989-DDA1-4ACA-B3EB-1E6C4DC9F99F Q35025863-43ABC578-99E7-4733-A3CA-631857A82DDF Q35029268-B60E89EC-3125-4E21-9314-C2323539D1F9 Q35130538-4B4B6CD3-B0D0-4EDC-9C02-994B6A2F1CDD Q35367168-4BD52D0E-B6C2-4BCF-8AC2-11DAFA3474C4 Q35373624-D19CDB02-29F0-4898-AB95-858FDF4D0E9B Q35376020-E7DFBDFB-D26A-4030-9F63-9102A1B219D7

P2860

Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.

http://www.wikidata.org/entity/Q37511097

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Roles of thromboxane A

@nl

Roles of thromboxane A(2) and ...... erosis in apoE-deficient mice.

@en

type

label

Roles of thromboxane A

@nl

Roles of thromboxane A(2) and ...... erosis in apoE-deficient mice.

@en

prefLabel

Roles of thromboxane A

@nl

Roles of thromboxane A(2) and ...... erosis in apoE-deficient mice.

@en

P1433

Q37511097-5C24A000-CA69-4983-A8E2-41F7D3BD9401

P1476

Q37511097-AD4EBD8C-8E1B-4764-9B45-891C3FFD601F

P2093

Q37511097-025B09A1-8495-48B8-8476-09D786769B14

Q37511097-04F33449-98A5-47C5-A581-93C67018E37D

Q37511097-24F66A90-7A46-4D15-AD62-9F6AB5AF0D94

Q37511097-28E4E8DA-63BD-4EA6-833D-77CD2327E307

Q37511097-82310985-514D-4128-BD6C-79B9E5903B11

Q37511097-884D8DDA-5EBA-46C0-96CA-F311B6E9944F

Q37511097-8CC37CC1-5E54-4221-A2E4-9472F80CC5A2

Q37511097-918EBF95-690D-4D70-BEB6-9FEDD99D6754

Q37511097-9AD24405-B355-44B8-BF87-6835E051B5A7

Q37511097-B33AC3F7-A990-4707-A2CC-78E48D651CD5

P2860

Q37511097-004BFF3B-DA1E-452A-BB8B-4B2ABD25E07D

Q37511097-02947306-6E23-4723-881A-502B4CC85F31

Q37511097-09042BE4-5907-498A-B44A-04AB5F238D4A

Q37511097-0B66787B-B019-45BD-961E-C26AC20C2DF5

Q37511097-15341B64-E497-4BA3-96E1-93E2913D12C0

Q37511097-1919959B-2047-43B5-A604-09C9C0DD7398

Q37511097-2019E98B-C82D-4C9C-8ECB-E2B4E3B246B0

Q37511097-207FCCA5-EC83-4447-9855-F560B2A21618

Q37511097-2335EDE3-2FA2-4744-A47B-C8F8C39146DA

Q37511097-2E9E1482-EA9B-4D6B-98EC-04F7689D79F6

P304

Q37511097-CA6EAE54-4402-45B9-B9EA-A50B5348AD4A

P31

Q37511097-4AF4413B-EC79-4B36-A7F1-5B75D5B9F8EB

P356

Q37511097-DD73FD3D-C42C-4FF5-AA5A-5A0806943226

P407

Q37511097-1D71D5D4-A61B-4123-8A08-6C33A99D2DF4

P433

Q37511097-23466D0B-9539-4B99-8BF4-E2375224AE07

P478

Q37511097-E2D7C136-7515-4DBB-8E1A-F83F1D7B235A

P577

Q37511097-BDAFFF74-8083-49BF-810E-E8C04FDDE1DE

P5875

Q37511097-10C42FAA-0CD2-4B7F-9482-59A165A6CE54

P698

Q37511097-497123F9-7A89-4462-AF89-2528936DFA56

P921

Q37511097-15E0CD3D-DC03-45C2-8F85-66BF4B6C6919

P932

Q37511097-3245C914-C657-4174-9D9C-085ABAAE3962

P356

P1433

Journal of Clinical Investigation

P1476

Roles of thromboxane A(2) and ...... erosis in apoE-deficient mice.

@en

P2093

Hidenori Arai

http://www.w3.org/2001/XMLSchema#string

Hideto Sano

http://www.w3.org/2001/XMLSchema#string

Hiroji Oida

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Katagiri

http://www.w3.org/2001/XMLSchema#string

Jun K Yamashita

http://www.w3.org/2001/XMLSchema#string

Masako Iguchi

http://www.w3.org/2001/XMLSchema#string

Masataka Majima

http://www.w3.org/2001/XMLSchema#string

Masayuki Yokode

http://www.w3.org/2001/XMLSchema#string

Mayumi Matsumoto

http://www.w3.org/2001/XMLSchema#string

Shuh Narumiya

http://www.w3.org/2001/XMLSchema#string

P2860

Role of prostacyclin in the cardiovascular response to thromboxane A2

Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

Cyclooxygenases 1 and 2

Adhesion receptors of the immune system

Prostanoid receptors: structures, properties, and functions

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

P304

784-794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200421446

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237149376

http://www.w3.org/2001/XMLSchema#string

P698

15372102

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

516261

http://www.w3.org/2001/XMLSchema#string